ETFOptimize | High-performance ETF-based Investment Strategies

Quantitative strategies, Wall Street-caliber research, and insightful market analysis since 1998.


ETFOptimize | HOME
Close Window

VSee Health (Nasdaq:VSEE) Secures Game-Changing 10M+ Teleradiology Contract, Igniting Explosive Growth in Booming Telehealth Sector

VSee multi-year teleradiology contract with a major level 1 hospital is set to double annual recurring revenue and pave the path for expanding services across the U.S.

SAN JOSE, CALIFORNIA / ACCESS Newswire / October 21, 2025 / VSee Health, Inc. (Nasdaq:VSEE), a trailblazing leader in telehealth innovation, is thrilled to announce a monumental multi-year teleradiology contract that catapults the Company into a new era of unprecedented growth and shareholder value creation. Executed on May 7, 2025, with service delivery underway since June 15, 2025, this landmark deal with a premier Level 1 hospital system is set to double VSee's annual recurring revenue and unlock a wealth of future opportunities in the rapidly expanding teleradiology market.

This transformative contract is projected to generate approximately $10 million in gross revenues over the next two years. Even more exhilarating, special provisions in the agreement pave the way for an additional $5+ million in potential revenue with similar margins, positioning VSee to capitalize on the surging demand for advanced telehealth solutions. As reflected in the Company's upcoming third quarter 10Q, revenue realization has already begun, marking a pivotal moment for VSee's financial trajectory. Shareholders can view the Company's stock performance details in the finance card above, showcasing VSEE's current price of $0.479 USD and a market cap of $8,123,227.67 as of October 20, 2025.

The teleradiology sector is experiencing explosive growth, driven by the increasing adoption of virtual care and the urgent need for scalable, high-quality diagnostic imaging solutions. VSee's partnership with a major, rapidly expanding hospital system positions the Company at the forefront of this dynamic market, with the potential to secure additional high-value contracts across the U.S. and beyond. Our cutting-edge, API-driven platform-integrating secure video, device data, and EHR connectivity-empowers healthcare providers to deliver world-class care, making VSee the go-to partner for hospitals and health networks seeking innovative telehealth solutions.

"This blockbuster contract is a game-changer for VSee Health and our shareholders," declared Co-CEO Dr. Imo Aisiku. "Doubling our annual recurring revenue is just the beginning. This partnership not only validates our leadership in teleradiology but also opens doors to a pipeline of future contracts with top-tier healthcare systems. We are uniquely positioned to ride the wave of the telehealth revolution, and we expect this to spark a period of explosive growth, delivering substantial value to our investors and transforming the future of healthcare delivery."

With the teleradiology market projected to grow at a compound annual growth rate (CAGR) of over 20% in the coming years, VSee's scalable platform and strategic partnerships position the Company to capture a significant share of this multi-billion-dollar industry. This contract is a springboard for further expansion, with VSee actively pursuing additional partnerships to fuel sustained revenue growth and solidify its dominance in the telehealth landscape.

About VSee Health

VSee Health (NASDAQ: VSEE) is a telehealth technology and services company delivering high-acuity virtual care solutions through its scalable, API-driven platform. The Company's offerings integrate secure video, device data, and EHR connectivity to power hospital systems, health networks, and employers across the United States. For more information, please visit vseehealth.com.

Forward-Looking Statements
Matters discussed in this news release that are not statements of historical or current facts, including but not limited to those relating to VSee Health's ability to improve healthcare access and provider efficiencies, are "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements may involve known and unknown risks, uncertainties and other factors that may cause performance or achievements to be materially different from historical results or from any future performance or achievements expressed or implied by such forward-looking statements. Accordingly, readers should not place undue reliance on any forward-looking statements. More information on risk factors relating to VSee Health and its technology and billing services is included from time to time in the "Cautionary Note Regarding Forward-Looking Statements,"; "Risk Factors"; and "Management's Discussion and Analysis of Financial Condition and Results of Operations"; sections of VSee Health's periodic and current filings with the SEC, which are also made available on VSee Health's website at vseehealth.com. Forward-looking statements speak only as of the date they are made, and VSee Health undertakes no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events or otherwise that occur after that date, or otherwise. Readers are cautioned not to put undue reliance on forward-looking statements.

Media Contact:
Anne Chang
VSee Health
media@vsee.com

VSee Investor Contact:
Milton Chen
VSee Health
investor@vsee.com

SOURCE: VSee Health, Inc.



View the original press release on ACCESS Newswire

Recent Quotes

View More
Symbol Price Change (%)
AMZN  220.69
+3.55 (1.63%)
AAPL  271.49
+5.24 (1.97%)
AMD  203.78
-2.24 (-1.09%)
BAC  51.56
+0.56 (1.10%)
GOOG  299.65
+9.67 (3.33%)
META  594.25
+5.10 (0.87%)
MSFT  472.12
-6.31 (-1.32%)
NVDA  178.88
-1.76 (-0.97%)
ORCL  198.76
-11.93 (-5.66%)
TSLA  391.09
-4.14 (-1.05%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.


 

IntelligentValue Home
Close Window

DISCLAIMER

All content herein is issued solely for informational purposes and is not to be construed as an offer to sell or the solicitation of an offer to buy, nor should it be interpreted as a recommendation to buy, hold or sell (short or otherwise) any security.  All opinions, analyses, and information included herein are based on sources believed to be reliable, but no representation or warranty of any kind, expressed or implied, is made including but not limited to any representation or warranty concerning accuracy, completeness, correctness, timeliness or appropriateness. We undertake no obligation to update such opinions, analysis or information. You should independently verify all information contained on this website. Some information is based on analysis of past performance or hypothetical performance results, which have inherent limitations. We make no representation that any particular equity or strategy will or is likely to achieve profits or losses similar to those shown. Shareholders, employees, writers, contractors, and affiliates associated with ETFOptimize.com may have ownership positions in the securities that are mentioned. If you are not sure if ETFs, algorithmic investing, or a particular investment is right for you, you are urged to consult with a Registered Investment Advisor (RIA). Neither this website nor anyone associated with producing its content are Registered Investment Advisors, and no attempt is made herein to substitute for personalized, professional investment advice. Neither ETFOptimize.com, Global Alpha Investments, Inc., nor its employees, service providers, associates, or affiliates are responsible for any investment losses you may incur as a result of using the information provided herein. Remember that past investment returns may not be indicative of future returns.

Copyright © 1998-2017 ETFOptimize.com, a publication of Optimized Investments, Inc. All rights reserved.